1. Brodsky, D, Christou, H. Current concepts in intrauterine growth restriction. J Intens Care Med. 2004; 19, 307–319.
2. Nardozza, LM, Araujo Júnior, E, Barbosa, MM, et al. Fetal growth restriction: current knowledge to the general Obs/Gyn. Arch Gynecol Obstet. 2012; 286, 1–13.
3. Cetin, I, Mando, C, Calabrese, S. Maternal predictors of intrauterine growth restriction. Curr Opin Clin Nutr Metab Care. 2013; 16, 310–319.
4. Baschat, AA. Fetal responses to placental insufficiency: an update. BJOG. 2004; 111, 1031–1041.
5. Ghidini, A. Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet Gynecol Surv. 1996; 51, 376–382.
6. Moore, LG, Niermeyer, S, Zamudio, S. Human adaptation to high altitude: regional and life-cycle perspectives. Am J Phys Anthropol. 1998; (Suppl. 27), 25–64.
7. Jensen, GM, Moore, LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health. 1997; 87, 1003–1007.
8. Mortola, JP, Frappell, PB, Aguero, L, Armstrong, K. Birth weight and altitude: a study in Peruvian communities. J Pediatr. 2000; 136, 324–329.
9. Giussani, DA, Niu, Y, Herrera, EA, et al. Heart disease link to fetal hypoxia and oxidative stress. Adv Exp Med Biol. 2014; 814, 77–87.
10. Ismail, H, Chang, YL. Sequelae of fetal growth restriction. J Med Ultrasound. 2012; 20, 191–200.
11. Saffery, R. Epigenetic change as the major mediator of fetal programming in humans: are we there yet? Ann Nutr Metab. 2014; 64, 203–207.
12. Puddu, M, Fanos, V, Podda, F, Zaffanello, M. The kidney from prenatal to adult life: perinatal programming and reduction of number of nephrons during development. Am J Nephrol. 2009; 30, 162–170.
13. Ritz, E, Amann, K, Koleganova, N, Benz, K. Prenatal programming-effects on blood pressure and renal function. Nat Rev Nephrol. 2011; 7, 137–144.
14. Dötsch, J, Alejandre-Alcazar, M, Janoschek, R, et al. Perinatal programming of renal function. Curr Opin Pediatr. 2016; 28, 188–194.
15. Miller, J, Turan, S, Baschat, AA. Fetal growth restriction. Semin Perinatol. 2008; 32, 274–280.
16. Rizzo, G, Arduini, D. Intrauterine growth restriction: diagnosis and management. A review. Minerva Ginecol. 2009; 61, 411–420.
17. Kouskouti, C, Regner, K, Knabl, J, Kainer, F. Cardiotocography and the evolution into computerised cardiotocography in the management of intrauterine growth restriction. Arch Gynecol Obstet. 2017; 295, 811–816.
18. Gonzalez-Bulnes, A, Astiz, S, Parraguez, VH, Garcia-Contreras, C, Vazquez-Gomez, M. Empowering translational research in fetal growth restriction: sheep and swine animal models. Curr Pharm Biotechnol. 2016; 17, 848–855.
19. Armitage, JA, Taylor, PD, Poston, L. Experimental models of developmental programming: consequences of exposure to an energy rich diet during development. J Physiol. 2005; 565, 3–8.
20. Schroeder, M, Shbiro, L, Zagoory-Sharon, O, Moran, TH, Weller, A. Toward an animal model of childhood-onset obesity: follow-up of OLETF rats during pregnancy and lactation. Am J Physiol Regul Integr Comp Physiol. 2009; 296, R224–R232.
21. Rosenfeld, CS. Animal models to study environmental epigenetics. Biol Reprod. 2010; 82, 473–488.
22. Neitzke, U, Harder, T, Schellong, K, et al. Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence. Placenta. 2008; 29, 246–254.
23. Neitzke, U, Harder, T, Plagemann, A. Intrauterine growth restriction and developmental programming of the metabolic syndrome: a critical appraisal. Microcirculation. 2011; 18, 304–311.
24. Charlton, V, Johengen, M. Effects of intrauterine nutritional supplementation on fetal growth retardation. Biol Neonate. 1985; 48, 125–142.
25. Symonds, ME, Budge, H, Stephenson, T, McMillen, IC. Fetal endocrinology and development-manipulation and adaptation to long-term nutritional and environmental challenges. Reproduction. 2001; 121, 853–862.
26. Wallace, JM, Aitken, RP, Milne, JS, Hay, WW. Nutritionally mediated placental growth restriction in the growing adolescent: consequences for the fetus. Biol Reprod. 2004; 71, 1055–1062.
27. Morel, O, Pachy, F, Chavatte-Palmer, P, et al. Correlation between utero-placental three-dimensional power Doppler indices and the uterine real blood flow: evaluation in a pregnant sheep experimental model. Ultrasound Obstet Gynecol. 2010; 36, 635–640.
28. Vonnahme, KA, Lemley, CO. Programming the offspring through altered uteroplacental hemodynamics: how maternal environment impacts uterine and umbilical blood flow in cattle, sheep and pigs. Reprod Fertil Develop. 2012; 24, 97–104.
29. Scherjon, SA, Smolders-DeHaas, H, Kok, JH, Zondervan, HA. The “brain-sparing” effect: antenatal cerebral Doppler findings in relation to neurologic outcome in very preterm infants. Am J Obstet Gynecol. 1993; 169, 169–175.
30. Osgerby, JC, Wathes, DC, Howard, D, Gadd, TS. The effect of maternal undernutrition on the placental growth trajectory and the uterine insulin-like growth factor axis in the pregnant ewe. J Endocrinol. 2004; 182, 89–103.
31. Zywicki, M, Blohowiak, SE, Magness, RR, Segar, JL, Kling, PJ. Increasing fetal ovine number per gestation alters fetal plasma clinical chemistry values. Physiol Rep. 2016; 4, e12905.
32. Unterscheider, J, Daly, S, Geary, MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO study. Am J Obstet Gynecol. 2013; 208, 290.e1–6.
33. Mureşan, D, Rotar, IC, Stamatian, F. The usefulness of fetal Doppler evaluation in early versus late onset intrauterine growth restriction. Review of the literature. Med Ultrason. 2016; 18, 103–109.
34. Shahinaj, R, Manoku, N, Kroi, E, Tasha, I. The value of the middle cerebral to umbilical artery Doppler ratio in the prediction of neonatal outcome in patient with preeclampsia and gestational hypertension. J Prenat Med. 2010; 4, 17–21.
35. DeVore, GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol. 2015; 213, 5–15.
36. Nassr, AA, Abdelmagied, AM, Shazly, SA. Fetal cerebro-placental ratio and adverse perinatal outcome: systematic review and meta-analysis of the association and diagnostic performance. J Perinat Med. 2016; 44, 249–256.
37. Albu, AR, Anca, AF, Horhoianu, VV, Horhoianu, IA. Predictive factors for intrauterine growth restriction. J Med Life. 2014; 7, 165–171.
38. Devoe, LD, Gardner, P, Dear, C, Faircloth, D. The significance of increasing umbilical artery systolic-diastolic ratios in third-trimester pregnancy. Obstet Gynecol. 1992; 80, 684–687.
39. Mensah, GA, Croft, JB, Giles, WH. The heart, kidney, and brain as target organs in hypertension. Cardiol Clin. 2002; 20, 225–247.
40. Vyas, S, Nicolaides, KH, Campbell, S. Renal artery flow-velocity waveforms in normal and hypoxemic fetuses. Am J Obstet Gynecol. 1989; 161, 168–172.
41. Arduini, D, Rizzo, G. Fetal renal artery velocity waveforms and amniotic fluid volume in growth-retarded and post-term fetuses. Obstet Gynecol. 1991; 77, 370–373.
42. Yoshimura, S, Masuzaki, H, Gotoh, H, Ishimaru, T. Fetal redistribution of blood flow and amniotic fluid volume in growth-retarded fetuses. Early Hum Dev. 1997; 47, 297–304.
43. Surányi, A, Streitman, K, Pál, A, et al. Fetal renal artery flow and renal echogenicity in the chronically hypoxic state. Pediatr Nephrol. 2000; 14, 393–399.
44. Stigter, RH, Mulder, EJH, Bruinse, HW, Visser, GHA. Doppler studies on the fetal renal artery in the severely growth-restricted fetus. Ultrasound Obstet Gynecol. 2001; 18, 141–145.
45. Arbeille, P. Fetal arterial Doppler-IUGR and hypoxia. Eur J Obstet Gynecol Reprod Biol. 1997; 75, 51–53.
46. Peeters, LLH, Sheldon, RE, Douglas-Jones, M, Makowski, EL, Meschia, G. Blood flow to fetal organs as a function of arterial oxygen content. Am J Obstet Gynecol. 1979; 135, 637–646.
47. Shepherdj, T, Abboudf, M. The renal circulation. In Handbook of Physiology (eds. Knox FG, Spielman WS), Section 2, vol. 3, 1983; pp. 205–209. American Physiological Society: Washington, DC.
48. Tanabe, R. Doppler ultrasonographic assessment of fetal renal artery blood flow velocity waveforms in intrauterine growth retarded fetuses. Kurume Med J. 1992; 39, 203–208.